Regenexx Email Format
Biotechnology ResearchIowa, United States51-200 Employees
Regenexx Corporate Program operates within the biotechnology research sector, focusing on regenerative medicine applications for orthopedic injuries. The program leverages stem cell treatments derived from bone marrow concentrate and licenses its injection methods to a network of physicians, aiming to provide non-surgical, lower-cost options for patients and to help self-funded employers manage orthopedic healthcare expenses. Through its corporate program, more than two thousand employer groups have integrated the Regenexx benefit into their self-funded health plans, offering employees access to therapies that address pain and functional limitations without resorting to surgery. The company is based in Des Moines, Iowa, and maintains a workforce of professionals involved in advancing regenerative technologies and related clinical applications. Regenexx emphasizes higher concentrations of stem cell–containing bone marrow through its lab processing, positioning itself as a specialized provider within the orthopedic regenerative medicine landscape.